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PURPOSE. Mutations in the ciliary transporter gene IFT140, usually associated with a severe
syndromic ciliopathy, may also cause isolated retinal dystrophy. A series of patients with
nonsyndromic retinitis pigmentosa (RP) due to IFT140 was investigated in this study.
METHODS. Five probands and available affected family members underwent detailed
phenotyping including retinal imaging and electrophysiology. Whole exome sequencing
was performed on two probands, a targeted sequencing panel of 176 retinal genes on a
further two, and whole genome sequencing on the fifth. Missense mutations of IFT140 were
further investigated in vitro using transient plasmid transfection of hTERT-RPE1 cells.
RESULTS. Eight affected patients from five families had preserved visual acuity until at least the
second decade; all had normal development without skeletal manifestations or renal failure at
age 13 to 67 years (mean, 42 years; median, 44.5 years). Bi-allelic mutations in IFT140 were
identified in all families including two novel mutations: c.2815T > C (p.Ser939Pro) and
c.1422_23insAA (p.Arg475Asnfs*14). Expression studies demonstrated a significantly reduced
number of cells showing localization of mutant IFT140 with the basal body for two
nonsyndromic mutations and two syndromic mutations compared with the wild type and a
polymorphism.
CONCLUSIONS. This study highlights the phenotype of nonsyndromic RP due to mutations in
IFT140 with milder retinal dystrophy than that associated with the syndromic disease.
Keywords: retinitis pigmentosa, ciliopathy, next-generation sequencing
The outer segments of photoreceptors are highly modified,photosensitive cilia, which lack any capability for protein
production.1 Thus, they are reliant on the intraflagellar
transport (IFT) system, which comprises large protein com-
plexes for transport from the cell body to cilium tip and back
driven by the motors kinesin-2 and dynein-2, respectively.2 The
IFT-B complex is essential for cilium assembly and anterograde
transport, whereas the IFT-A complex is responsible for
retrograde transport, with additional roles in anterograde
transport by connecting kinesin to the IFT complex and in
facilitating entry of proteins in to the cilium.3,4 IFT140, a
subunit of IFT-A, is vital for both the development and the
maintenance of outer segments and has a specific role in opsin
transport across the connecting cilium.2
Mutations in IFT140 have been associated with Jeune
asphyxiating thoracic dystrophy and Mainzer-Saldino syndrome,
ciliopathies forming part of a spectrum of skeletal dysplasias
now collectively termed short rib thoracic dysplasia 9 with or
without polydactyly (SRTD9, mendelian inheritance in man
[MIM]#266920).5–7 First described in 1970, patients have
variable skeletal features including shortened ribs, short
stature, cone-shaped phalangeal epiphyses (prepubertal), bra-
chymesophalangy, and acetabular spurring or metaphyseal
defect of the femoral head.8 Nonskeletal features in the
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majority of patients include a severe early-onset retinal
dystrophy and end-stage renal failure secondary to nephro-
nophthisis by the teenage years, with cerebellar ataxia,
epilepsy, facial dysmorphism, learning difficulties, and chole-
stasis also reported.5–7
Retinitis pigmentosa (RP) is the most common form of
inherited retinal dystrophy, with more than 60 genes associ-
ated with the nonsyndromic, recessive form.9–12 These include
ciliopathy genes such as CEP290 and BBS1, which manifest
both syndromic and nonsyndromic phenotypes.13,14 Recently,
IFT140mutations have been identified in patients with isolated
retinal dystrophy.15,16 The present study reports eight patients
from five families with isolated retinal dystrophy and bi-allelic
IFT140 variants with detailed characterization of the ocular
phenotype. Functional analysis of two of these variants with
protein localization studies in hTERT-RPE1 cells supports their
pathogenicity.
MATERIALS AND METHODS
The study protocol adhered to the tenets of the Declaration of
Helsinki and received approval from the local ethics commit-
tees. Written informed consent was obtained from all
participants prior to their inclusion in this study, with parental
written consent provided on behalf of the children involved in
this study.
Clinical Evaluation
Each proband with IFT140-related retinal dystrophy and
available affected family members underwent a full clinical
examination including visual acuity and dilated fundus
examination. Retinal fundus imaging was obtained by conven-
tional 358 fundus color photographs (Topcon Great Britain,
Ltd., Berkshire, UK), fundus autofluorescence (FAF) imaging
using 308 or 558 Spectralis (Heidelberg Engineering, Ltd.,
Heidelberg, Germany) or ultra-widefield confocal scanning
laser imaging (Optos plc, Dunfermline, UK), and either Stratus
optical coherence tomography (OCT; Carl Zeiss Meditec, Inc.,
Dublin, CA, USA) or Spectralis OCT (Heidelberg Engineering
Ltd.). Full field and pattern electroretinography were per-
formed using gold foil electrodes to incorporate the Interna-
tional Society for Clinical Electrophysiology of Vision (ISCEV)
standards.17,18 Renal function was performed in all available
patients, with skeletal x-rays in five patients.
Molecular Investigations
Genomic DNAwas isolated from peripheral blood lymphocytes
using the Puregene kit (Gentra Puregene Blood Extraction Kit,
Qiagen, Manchester, UK).
Patient 1.1 was initially negative for known retinal
dystrophy variants using an arrayed primer extension (APEX)-
based test (Asper Biotech, Ltd., Tartu, Estonia) using a
genotyping microarray containing >300 disease causing
variants and common polymorphisms for eight retinal dystro-
phy genes (AIPL1, CRB1, CRX, GUCY2D, RPE65, RPGRIP1,
LRAT, and MERTK) as previously described.19 He was then
found negative by targeted next-generation sequencing (NGS)
of the coding regions of 31 retinal dystrophy genes performed
at the Bioscientia Center for Human Genetics (Ingelheim,
Germany) using the Genome Sequencer FLX system (Roche,
Basel, Switzerland), enriched using a Roche/NimbleGen
sequence capture and analyzed using Roche GS Reference
Mapper (version 2.5.3) and JSI Medical Systems Software
(version 3.5; Ettenheim, Germany). Whole exome sequencing
(WES) was performed at AROS Applied Biotechnology using a
solution-phase Agilent SureSelect 38-Mb exome capture (Sure-
Select Human All Exon Kit; Agilent Technologies, Inc., Santa
Clara, CA, USA) and the Illumina HiSeq 2000 sequencer
(Illumina, Inc., San Diego, CA, USA). Reads were aligned to the
hg19 human reference sequence using Novoalign (Novocraft,
Selangor, Malaysia), version 2.05. The ANNOVAR tool (Open-
bioinformatics.org) was used to annotate single nucleotide
polymorphisms (SNPs) and small insertions/deletions.
Patient 2 was initially investigated as part of the UK National
Collaborative Usher study due to the coexistence of hearing
loss with retinal dystrophy with negative bi-directional Sanger
sequencing of nine Usher genes (MYO7A, CDH23, PCDH15,
USH1C, USH1G, USH2A, GPR98, WHRN, and CLRN1) and a
candidate gene SLC4A7 as previously described.20 WES was
then performed as above.
Patients 3.1 and 5 underwent NGS of the coding regions of
176 retinal genes at the Manchester Centre for Genomic
Medicine (Manchester, UK) with enrichment using a SureSelect
Target Enrichment Kit (Agilent Technologies, Inc.) and then
sequenced on the HiSeq 2500 (Illumina, Inc.). Sequenced reads
were aligned to the human reference sequence hg19 (build
GRCh37) with the Burrows-Wheeler aligner (BWA v0.6.2).21
The genome analysis tool kit (GATKlite v2.0.39) was used for
base quality score recalibration and indel realignment prior to
variant calling using the UnifiedGenotyper.22
Patient 4 underwent whole genome sequencing (WGS) as
part of the National Institute for Health Research (NIHR)
BioResource- Rare Diseases study using the Illumina TruSeq
DNA PCR-Free Sample preparation kit (Illumina, Inc.) and
sequenced using an Illumina HiSeq 2500, generating minimum
coverage of 153 for approximately 95% of the genome. Reads
were aligned to the Genome Reference Consortium human
genome build 37 (GRCh37) using Isaac Genome Alignment
Software (version 01.14; Illumina, Inc.).23 Single nucleotide
variations and small insertion deletions were identified using
Isaac Variant Caller (version 2.0.17).
Bi-directional Sanger sequencing of involved exons and
intron-exon boundaries of IFT140 was performed on all
patients and segregation confirmed in available relatives.
DNA was amplified using specifically designed primers by
polymerase chain reaction (PCR), and the resulting fragments
were sequenced using standard protocols (information on
request).
Nomenclature was assigned in accordance with GenBank
accession number NM_014714.3 with nucleotide position 1
corresponding to the A of the ATG translation initiation codon.
Variants were identified as novel if not previously reported in
the literature and if absent from dbSNP, which is available at
http://www.ncbi.nlm.nih.gov/projects/SNP/, NHLBI GO
Exome Sequencing Project (ESP; Seattle, WA, USA), which is
available at http://evs.gs.washington.edu/EVS/, 1000 genomes
project, which is available at http://www.1000genomes.org/,
and the Exome aggregation Consortium (ExAC; Cambridge,
MA, USA), which is available at http://exac.broadinstitute.org.
All were accessed on November 25, 2015.24 The likely
pathogenicity of novel missense variants was assessed using
the predictive algorithms of sorting intolerant from tolerant
(SIFT), available at http://sift.jcvi.org, and polymorphism
phenotyping v2 (PolyPhen-2), available at http://genetics.
bwh.harvard.edu/pph2, and the conservation of the residues
throughout the species was analyzed using Clustal Omega,
accessed at http://www.ebi.ac.uk/Tools/msa/clustalo/, with
protein sequences identified from Ensembl, which was
accessed at http://www.ensembl.org.25–28 Where relevant,
potential splice site disruption was assessed using Splice Site
Prediction by Neural Network at http://www.fruitfly.org/seq_
tools/splice.html.29
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Cell Transfection Studies
Site-directed mutagenesis using mutation-specific complemen-
tary primer pairs (Supplementary Table S1) generated four
plasmid clones using pCMV-IFT140-Myc-DDK (RC207528;
Origene, Rockville, MD, USA). Cultured hTERT-RPE1 cells
were seeded at 13105 cells/mL, and transient transfection was
achieved using Lipofectamine LTX reagent with PLUS (Life
Technologies, Paisley, UK). After incubation in OptiMEM-I
reduced serum medium (Life Technologies) for 24 hours at
378C in 5% CO2, cells were fixated with 4% paraformaldehyde
in PBS and then permeabilized with 0.5% Triton X-100 (Sigma-
Aldrich, Inc., St. Louis, MO, USA) in PBS. Cells were
immunostained with primary antibodies to the C-terminal
Myc-DDK tag of the plasmid (1:5000 rat anti-DYKDDDDK tag
antibody, 200473; Agilent Technologies) and basal body
(1:1000 rabbit anti-pericentrin; Sigma-Aldrich, Dorset, UK);
secondarily stained with 1:300 donkey Alexa Fluor 488–
conjugated anti-rat (Life Technologies) and 1:300 donkey Alexa
Fluor 647–conjugated anti-rabbit (Life Technologies); and
mounted with ProLong Gold Antifade Mountant with DAPI
(Life Technologies). Cells were imaged with confocal micros-
copy (Zeiss LSM 700; Carl Zeiss Microscopy, Ltd., Cambridge,
UK). The percentage of transfected cells with localization of
IFT140 to the basal body was calculated from a mean of three
independent experiments with >100 cells counted per
experiment (statistical analysis with a one-way analysis of
variance and post hoc comparison using a Bonferroni
correction; IBM SPSS Statistics version 22, IBM Corporation,
New York, USA).
RESULTS
Ophthalmologic and Systemic Findings
Clinical details are summarized in Table 1, with clinical imaging
described in Figure 1. All patients had a retinal dystrophy
characterized by nyctalopia and progressive field loss, with
fundus features and electrophysiology (available in three
patients) consistent with RP.
Family 1 of Northern Pakistan origin was comprised of the
proband (patient 1.1) and his affected second cousins; two of
the three affected second cousins (patients 1.2 and 1.3) were
available for clinical examination. Patient 1.1 was born at full
term to consanguineous parents. He was noted to have
reduced night vision at 2 years of age. Fundus examination
demonstrated mild midperipheral retinal changes only (Fig. 1).
Electroretinography (ERG) performed at age 8 demonstrated a
relatively severe rod-cone dystrophy with marked bilateral
macular involvement that had progressed when repeated at
age 13 years. Systemically, patient 1.1 was well with no
dysmorphic features. At age 13, his height was in the 50th–
75th centile, weight in the 75th centile, and head circumfer-
ence in the 25th centile. His fingers were noted to be long, and
he had no skeletal abnormalities. Hand and hip x-rays were
normal (Supplementary Fig. S1). He had a history of congenital
right pelvico-ureteric junction obstruction and secondary
hydronephrosis, which required surgical correction at 4 years
of age. Renal and liver function blood tests were normal at age
13 years, and renal ultrasound demonstrated a normal left
kidney. On the right, there was global cortical thinning and loss
of normal corticomedullary differentiation consistent with the
history of hydronephrosis.
Blood samples were obtained from all three affected second
cousins of patient 1.1 to confirm segregation (Fig. 2).
Assessment and investigation was possible for the two male
patients: 1.2 and 1.3. Both developed visual symptoms in
childhood with preservation of central vision until their 40s.
Both had retinal changes of RP with attenuated vessels, macular
atrophy, and midperipheral pigmentary change, which was
worse in the older brother. Neither brother had any syndromic
features. Specifically, hand x-rays did not demonstrate shortened
phalanges, and renal and liver function was normal.
Patient 2, of Caucasian British origin, first noticed nyctalo-
pia at age 16 years, with peripheral field loss noted in his mid-
20s when he was diagnosed with RP. Loss of central vision
occurred by 50 years of age, with fundus features of a severe
and extensive pigmentary retinopathy. There was no history of
skeletal or renal abnormalities. A hand x-ray did not identify
shortened phalanges, and renal function blood tests were
normal at age 67 years (Supplementary Fig. S1). There was a
history of progressive hearing loss noted at the age of 4 years,
which required hearing aids. Audiometry revealed symmetrical
bilateral high-frequency loss and bilateral plateau loss of 25 to
30 db in 250- to 2000-kHz frequencies. The hearing loss was
atypical for Usher syndrome. There was no other medical
history of note. His younger sister also has RP but without
hearing loss. Clinical examination was not possible, but a DNA
sample was obtained.
Family 3 is from the Gujarat region of India. The proband,
patient 3.1, noted nyctalopia in his late 20s and problems with
glare. He noted reduced left vision at age 44 years. Fundus
examination revealed extensive pigmentary change and vessel
attenuation. An ERG was consistent with severe generalized
retinal dysfunction in both eyes. Patient 3.2 presented with
nyctalopia and progressive peripheral field loss in her early
30s. When last reviewed at age 57, visual acuity was still good
at 0.2 logMAR each eye (Snellen 20/32), despite marked vessel
attenuation and generalized atrophy of the posterior pole.
Neither patient has any systemic manifestations. Both patients
have normal serum creatinine but estimated glomerular
filtration rates (GFRs) that are borderline and under review.
Both are hypertensive on oral medications. Patient 3.2 has had
stable creatinine and GFR over 6 years of monitoring.
Family 4 is from the Punjab region of Pakistan. The proband
developed nyctalopia in the early teenage years without any
other noticeable symptoms. An ERG was consistent with a
severe rod-cone dystrophy. When last reviewed at age 26 years,
the patient was systemically well with no clinically apparent
syndromic features of disease. Further investigations were
unfortunately not possible as the patient is no longer
contactable.
Family 5 is British Caucasian. The proband noted difficulty
with dark and light adaptation in his late 20s but otherwise
remains without symptoms. At last review at age 31 years, the
visual acuity was right 0.0 logMAR, left0.1 logMAR, with mild
retinal changes only. He was systemically well, with normal renal
function and ultrasound. A skeletal survey was also normal.
Molecular Investigations
In family 1, WES identified a homozygous variant, c.1451C >
T(p.Thr484Met), with segregation in five unaffected and three
affected family members supporting causality (Table 2; Fig. 2).
This variant has been previously reported.16 No other
predicted pathogenic variants were identified in known retinal
genes. In family 2, WES identified a splice site variant
c.2399þ1G > T that has been previously reported in four
syndromic patients and a novel missense variant, c.2815T > C
(p.Ser939Pro) predicted to be tolerated in silico.5,6 Patient 2’s
affected sister also carries both variants, with his son carrying
the missense variant only, confirming that the mutations are in
trans.5,6
A targeted gene panel of 176 genes identified an
apparent homozygous variant c.998G > A(p.Cys333Tyr) in
the third proband. This was also present in two other
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affected family members, with one unaffected sibling not
harboring the variant; parental DNA was unavailable. It is
therefore possible, in this nonconsanguineous family, that
the affected patients are hemizygous with a deletion on the
other allele. This variant has not been reported in an
affected patient before but is present in 2 of 121,370 alleles
on ExAC.
WGS identified the same homozygous variant in a fourth
unrelated family (patient 4). Affected and unaffected family
members overseas were unavailable for further testing.
FIGURE 1. Retinal imaging in IFT140-related retinal dystrophy: (a) color fundus photographs, (b) fundus autofluorescence, and (c) optical coherence
tomography. Patient 1.1, age 13 years, right eye: (a) diffuse, midperipheral white dots with para-foveal early atrophy in the macula (arrow), (b)
midperipheral reduced autofluorescence in area of white dots with central increased ring of increased autofluorescence in macula, and (c) centrally
preserved inner segment ellipsoid (ISe) band. Patient 1.2, age 45 years, left eye: (a) central macula atrophy with peripheral intraretinal pigmentary
migration in regions of depigmentation. Patient 1.3, age 44 years, left eye: (a) centralmacular atrophywithmidperipheral hypopigmentary dots. Patient 2,
age 67 years, left eye: (a) posterior pole atrophy with heavymidperipheral pigmentary change, (b) extensive loss of autofluorescence throughout retina,
particularly inmidperiphery, and (c) extensive lossofouter retina and innerchoroid. Patient 3.2, age57years, right eye: (a)macular atrophy,midperipheral
RPE atrophy, and pigment change with marked vessel attenuation and vessel occlusion nasally, (b) widespread reduced autofluorescence particularly in
posterior pole, and (c) disorganized retina with loss of outer retina and outer retinal tubulation (arrow). Patient 4, age 26 years, right eye: (a) mild
midperipheral RPE atrophy, (b) ring of increased autofluorescence in macula with small dots of reduced autofluorescence nasally, and (c) ISe band
preservedcentrally in regioncorresponding to the FAF increased ring. Patient 5, age 30years, right eye: (a) attenuatedvessels,midperipheralRPEmottling/
hypopigmentation, (b) ring of increased autofluorescence in the macula, speckled reduction in the midperiphery, and (c) ISe band preserved centrally.
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Patient 5 also underwent targeted sequencing of 176 retinal
genes, identifying two variants. The first, c.1021G > A
(p.Ala341Thr), has an allele frequency of 10 in 119,692 on
ExAC and is predicted to be damaging in silico (SIFT 0.03,
Polyphen2 1.00). The second is a novel frameshifting mutation,
c.1422_1423insAA (p.Arg475Asnfs*14). Segregation in his
parents confirmed the mutations to be in trans.
Conservation of the missense variants identified in this
study was compared to syndromic missense variants across a
diverse range of orthologues (Supplementary Fig. S2).
Ala341Thr, Thr484Met, and Ser939Pro are not conserved,
and Cys333Tyr is fully conserved. Six of nine syndromic
missense mutations are fully conserved, and three are not
conserved.
Localization of IFT140 and Mutants in hTERT-RPE1
Cells
Site-directed mutagenesis using mutation-specific complemen-
tary primer pairs (Supplementary Table S1) generated four
plasmid clones. Mutagenesis was confirmed by sequencing of
the entire open reading frame. A total of six plasmids were
used in cell transfection experiments: two contained non-
syndromic mutations c.1451C > T(p.Thr484Met, T484M) and
c.2815T > C (p.Ser939Pro, S939P); one previously unreported
mutation, c.1319T > C (p.Leu440Pro, L440P), from a patient
with Leber congenital amaurosis and renal failure (Perrault I,
written communication, 2015); a previously reported plasmid
with a syndromic mutation c.1990G > A (p.Glu664Ly-
s,E664K)5; the WT plasmid; and a polymorphism, c.2330T >
G (p.Leu777Arg, L777R), rs34535263. Following transient
transfection of IFT140 plasmids in hTERT-RPE1 cells and
subsequent immunostaining, analysis of aberrant IFT140
localization with the basal body was performed (Fig. 3). Mean
transfection efficiency was 38%, with generalized cytoplasmic
staining frequently observed. Those cells with specific basal
body labeling by IFT140 were counted. Statistically significant
aberrant localization was found for T484M, S939P, L440P, and
E664K compared with WT and L777R (P < 0.0001). No
significant difference was found between T484M, S939P,
L440P, and E664K (P ¼ 1) or between T484M and S939P
compared with the syndromic mutants L440P and E664K.
DISCUSSION
This report describes the association of IFT140 mutations and
nonsyndromic retinal dystrophy. A strength of this present
study in addition to detailed ophthalmic phenotyping is the
FIGURE 2. Pedigrees and variant segregation for the five families.
TABLE 2. Summary of Molecular Results With Predicted Pathogenicity and Previous Reports









1 c.1451C > T p.Thr484Met 0.02 0.980 Xu 201516 5 of 120,980
2 c.2399þ1G > T Abolish strong donor site — — Perrault 20125 4 of 66,732
c.2815T > C p.Ser939Pro 0.22 0.155 Novel Not found
3 and 4 c.998G > A p.Cys333Tyr 1.00 0.991 Not reported 2 of 121,370
5 c.1021G > A p.Ala341Thr 0.03 1.000 Not reported 10 of 66,132
c.1422_23insAA p.Arg475Asnfs*14 — — Novel Not found
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FIGURE 3. Aberrant localization of IFT140 with basal bodies in transiently transfected hTERT-RPE1 cells. (A) Six Myc-DDK–tagged IFT140 plasmid
constructs comprising wild type (WT) and five mutants: L440P (syndromic), T484M (nonsyndromic), E664K (syndromic), L777R (polymorphism),
and S939P (nonsyndromic). Cells were immunostained with primary antibodies to the IFT140 plasmid (rat anti-DYKDDDDK Tag antibody), and
basal body (rabbit anti-pericentrin) and secondarily stained with donkey anti-rat and donkey anti-rabbit. Cells were visualized with Zeiss confocal
microscopy. Expressed IFT140 (white arrow) and basal body localization were reduced in all mutants compared with WT and a single nucleotide
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systemic investigation of all but one patient, as well as
including five patients in their fifth to seventh decades, which
is far older than any previously reported patients. The patients
have typical features of RP presenting from early childhood to
the fourth decade, and all are developmentally normal, with no
apparent skeletal or neurological abnormalities. Cone-shaped
epiphyses are universally found prepubertally in IFT140-
related syndromic disease. This abnormality is not apparent
in adults, although shortening of the phalanges can still be
detected.30 Prepubertal hand and pelvic x-rays in patient 1.1
were normal. In patients 1.2, 1.3, 2, and 5, hand x-rays did not
identify shortened phalanges, but it remains possible that x-
rays during childhood could have revealed evidence of the
cone shape abnormality. Seven of eight patients were available
for renal investigations. Renal function was normal except for
patients 3.1 and 3.2, with borderline renal function at age 53
and 57 years, respectively. It is possible that this mild renal
impairment is related to IFT140, but given their age and
hypertension, it may be unrelated. Patient 1.1 had a unilateral
congenital pelvico-ureteric obstruction surgically repaired.
This abnormality has not been reported in IFT140-related
disease, and the other kidney is structurally normal on
ultrasound; it is likely that this is an incidental finding. His
two older affected second cousins have normal renal function
in their 40s.
All but one of the previously reported syndromic patients
with IFT140 mutations had a severe, early-onset retinal
dystrophy and undetectable or severely attenuated ERG.5–7
The exception, a patient homozygous for c.699T > G
(p.Ile233Met), had no evidence of retinal dystrophy at age 2
years but did have skeletal and renal manifestations.5 Of seven
patients recently reported with isolated retinal dystrophy due
to IFT140, five have RP with onset of nyctalopia ranging from 7
to 33 years old, and two have severe early-onset retinal
dystrophy.15 There was no evidence of renal or skeletal
involvement, but one patient had hypogonadism and fatty
liver, which have been reported in other ciliopathies. It was
not clear if all patients underwent systemic investigation and
renal function. A further report of 12 patients focused on the
ophthalmic phenotype, describing it as severe with infantile
onset, hyperopia, and flat ERG (age, <2–20 years). The patients
reported in this present study have milder and later onset
retinal dystrophy than the majority of those previously
reported with fundus features consistent with RP. Refraction,
available in two patients, was myopic.
All reported patients with syndromic forms of IFT140-
related ciliopathy have developed end-stage renal failure by
their second decade, with the exception of 10 families
homozygous for p.Glu664Lys (reported ages, 10 months to
17 years).5–7,16 The affected children in these families
presented in infancy with severe early-onset retinal dystrophy
consistent with a diagnosis of Leber congenital amaurosis and
with additional syndromic findings including epilepsy, hypoto-
nia, and developmental delay. In all patients in whom hand x-
rays were performed, cone-shaped epiphyses were identified.
Systemic investigations were unavailable for four families.16
The lack of overt renal dysfunction suggests a possible
genotype–phenotype correlation for this specific muta-
tion.5,7,16 However, there has been one reported patient
homozygous for this variant, with renal failure and kidney
transplant age at 17 years, raising the possibility that renal
dysfunction may still occur with this allele but perhaps later
than with other syndromic disease alleles.16
Phenotypic heterogeneity of several ciliopathy genes has
been well established, including CEP290, IQCB1, IFT172,
BBS1, and BBS3.13,14,31–33 In the case of CEP290, there is
evidence for a dosage-dependent phenotype with bi-allelic loss
of function mutations associated with Joubert syndrome and
the common c.2991þ1655A > G splicing mutation, in which a
small amount of protein is still produced, associated with Leber
congenital amaurosis.13 In addition, CEP290 mutations in
functionally critical regions, despite predicted residual protein
production, were associated with a more severe phenotype.34
Three nonsyndromic families in this report have bi-allelic
missense variants, as do several of the previously reported
syndromic families (Supplementary Table S2).5–7 This would
suggest that phenotypic variability is not related to the type of
mutation. Only one patient with bi-allelic premature termina-
tion codons has been reported, which may indicate an
essential developmental role for IFT140.16 Mice homozygous
for Ift140/ die midgestation, indicating embryonic lethality
for a null phenotype.35
IFT140 is a 1462-amino-acid protein encoded by 31 exons
and consists of two types of domain; five WD repeats and nine
tetratricopeptide repeats.36 Reported mutations arise through-
out the gene with no clustering or domain preference. Of the
four missense variants in this report, p.Cys333Tyr and
p.Ala341Thr arise within the WD5 domain but the other two
are not located within known functional domains. Of the
previously reported syndromic mutations, two arise within
functional domains (p.Val292Met and p.Tyr311Cys in WD4)
and the remaining seven do not. Conservation of missense
amino acid residues in orthologues demonstrates a lack of
conservation of three of the nonsyndromic residues, with one
fully conserved. Three of nine syndromic mutations are not
conserved, precluding any conclusion (Supplementary Fig. S2).
The Cys333Tyr allele was identified in two families, and it
would suggest that this may be a retina-specific allele. The
variant Thr484Met was recently identified in conjunction with
a second missense variant in a patient with nonsyndromic
Leber congenital amaurosis, indicating that this allele may also
be retina specific. The nonconserved Ala341Thr variant was
identified in a patient with a novel frameshifting variant, which
has not been reported in an affected patient before. The
nonconserved Ser939Pro residue is predicted to be tolerated in
silico and arises in conjunction with a splice site variant
previously reported in syndromic disease. These results may
indicate that the Ala341Thr and Ser939Pro variants are less
deleterious to protein function such that there is a non-
syndromic manifestation of disease.
Transient expression of IFT140 in hTERT-RPE1 cells
transfected with a Myc-DDK–tagged IFT140 plasmid demon-
strates localization of IFT140 with the basal body. This was
significantly reduced in mutant cells compared with WT and
L777R cells (P < 0.0001). No difference was found between
the two missense variants from families in this report and the
two reported syndromic missense variants, indicating a
deleterious effect on protein trafficking in vitro for all mutants
studied. This supports causality of these two nonsyndromic
missense variants in vitro.
polymorphism, L777R. Scale bar. 20 lm. (B) The percentage of transfected cells with localization of IFT140 to the basal body was calculated from a
mean of three independent experiments with >100 cells counted per experiment. A statistically significant difference was found between WT and
E664K, L440P, T484M, and S939P (***P < 0.0001) and between L777R and E664K, L440P, T484M, and S939P (P < 0.0001), with no difference
between WT and L777R (P¼ 1). There was also no statistically significant difference found between the syndromic mutants, E664K and L440P, and
the T484M and S939P mutants (P¼ 1).
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In this report, five families with apparently isolated RP due
to IFT140 mutations are characterized. Given the potential for
systemic complications, children with apparently isolated
retinal dystrophy due to IFT140 mutations may need long-
term systemic investigation and renal function monitoring.
However, it is likely that some patients will have lifelong
isolated retinal disease, and as more patients are reported,
specific allele phenotypes may emerge.
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